Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Cresco Labs Inc (OP:CRLBF)

0.5109 -0.0141 (-2.69%)
Streaming Delayed Price Updated: 3:50 PM EDT, Jul 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cresco Labs Inc

< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Cannabis Stock Movers For April 17, 2025
Via Benzinga
Topics Cannabis
Cannabis Stock Gainers And Losers From April 11, 2025
Via Benzinga
Topics Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For April 9, 2025
Via Benzinga
Topics Cannabis
Cannabis Stock Gainers And Losers From April 8, 2025
Via Benzinga
Topics Cannabis
Marijuana Stock Movers For April 7, 2025
Via Benzinga
Topics Cannabis
Marijuana Stock Movers For April 4, 2025
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For April 3, 2025
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For April 2, 2025
Via Benzinga
Topics Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For April 1, 2025
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For March 31, 2025
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For March 18, 2025
Via Benzinga
Topics Cannabis
Marijuana Stock Movers For March 14, 2025
Via Benzinga
Topics Cannabis
This Week In Cannabis: Earnings, Europe's Buzzing Scene, The UN And More
Cannabis news this week: California extends hemp ban, UN schedules HHC, major earnings reports & Tilray expands. 
Via Benzinga
Topics Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For March 13, 2025
Via Benzinga
Topics Cannabis
Cannabis Firm Cresco Labs Reports Mixed Q4, CEO Says Company Will 'Strategically Deploy Capital To Create Growth' In 2025
Cresco Labs posts Q4 revenue of $175.91M, beating estimates. The company secured a Tier 3 cultivation license in Kentucky, expanding its market presence. 
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For March 10, 2025
Via Benzinga
Topics Cannabis
Cannabis Stock Valuations Reflect No Expectation Of Federal Reform: Study
Viridian Capital's latest report shows cannabis stocks pricing in no rescheduling or 280E relief, leaving MSOs stuck in valuation limbo. 
Via Benzinga
Topics Cannabis
'President Trump's Endorsement Represents A Sea Change In Cannabis Policy,' Says Trulieve CEO As Advocacy Groups Join Forces
"Our new combined organization will best position the industry to help the President get them over the finish line," says Trulieve CEO Kim Rivers. 
Via Benzinga
Topics Cannabis Government
Cannabis Stock Movers For January 9, 2025
Via Benzinga
Topics Cannabis
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review. 
Via Benzinga
Topics Cannabis
EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'
Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop. 
Via Benzinga
Topics Cannabis
The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns
New Lake Capital Partners (OTC:NLCP), a real estate company focused on cannabis properties, offers an attractive investment with a 9.1% dividend yield, well above the return on 10-year government... 
Via Benzinga
Topics Cannabis
Illinois Cannabis Sales Back On Track In October Hitting $142.3M After Slight September Dip
ollowing a drop in September cannabis sales numbers in Illinois, October figures totaled $142.3 million, a 4.2% increase sequentially, reported New Cannabis Ventures' Alan Brochstein. Cannabis sales... 
Via Benzinga
Topics Cannabis
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector. 
Via Benzinga
Topics Cannabis
Federal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030
According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%. 
Via Benzinga
Topics Cannabis
80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?
According to Z&A, its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x. 
Via Benzinga
Best And Worst Performing States For Cannabis Sales In 2024: YTD Winners & Losers
BDSA's October 2024 data highlights Maryland as the fastest-growing state for cannabis sales, with a year-to-date increase of 57.8%. 
Via Benzinga
Topics Cannabis
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56. 
Via Benzinga
Topics Cannabis ETFs Government
Can Trump's Return Save The Cannabis Sector? Debt Mounts As Giants Face Post-Election Reckoning
The post-election landscape raises uncertainty for cannabis MSOs, with investors hoping for potential relief from the new administration. 
Via Benzinga
Topics Cannabis Government
Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General
Donald Trump nominated Rep. Matt Gaetz as attorney general, who has supported cannabis legalization and proposed ending cannabis testing for military recruitment. 
Via Benzinga
Topics Cannabis Government
< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.